Compound ID | 293
Class: Beta-lactam
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor |
| Target Pathogen: | Active against Pseudomonas aeruginosa |
| Combined with other compounds: | In preclinical trials was coadministered with cilastatin |
| Description: | A dehydropeptidase I stable carbapenem; shows good safety profile |
| Institute where first reported: | Daiichi Sankyo Pharmaceutical, Japan |
| Year first mentioned: | 1992 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/9871971 |
| Citation: | https://academic.oup.com/jac/article/38/2/287/794897/In-vitro-interactions-of-DX-8739-a-new-carbapenem |